InsidersTradesSigma
Total declarations
Companies
▲ Purchases (2 ops.)
▼ Sales (3 ops.)
Insider track record
CEODisclosed buys
2
Disclosed sells
3
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the full record of transactions filed by Klassen Preston, Chief Executive Officer. Director active across 3 companies, notably Metacrine, Inc.. In total, 11 disclosures have been recorded. Breakdown: 2 buys · 3 sells. Total volume traded: €325k. Activity tracked since 20 May 2021. The latest transaction was filed on 13 January 2025 (Cession). Regulator: SEC (Form 4). All data is openly available.
Declarations11 total
31,445 shares@ US$1.263244.0% of flowCommon StockSEC:0000950170-25-005880:0
37,500 shares@ US$1.3656.0% of flowCommon StockSEC:0000950170-25-004269:0
842,211 shares@ US$0.4756.0% of flowCommon StockSEC:0001209191-23-020882:0
380,605 shares@ US$0.413222.1% of flowCommon StockSEC:0001209191-23-005271:0
43,575 shares@ US$0.502114.2% of flowCommon StockSEC:0001209191-22-024951:0
104,500 shares0Common StockSEC:0001209191-22-024631:0
842,211 shares0Common StockSEC:0001209191-22-014081:0
20,547 shares@ US$3.635242.9% of flowCommon StockSEC:0001209191-21-034596
Ideal exit: 14 Feb 2022 (T+270)
20,547 shares@ US$3.635242.9% of flowCommon StockSEC:0001209191-21-034596:0
Ideal exit: 14 Feb 2022 (T+270)
1,860 sharesCommon StockSEC:0001209191-16-095647:0
4,170 sharesCommon StockSEC:0001209191-16-095647:1
11 of 11 declarations
About Klassen Preston
Preston Klassen is the President and Chief Executive Officer of Metacrine, Inc. He leads the company with a strategic vision and a commitment to innovation. His role involves overseeing daily operations and implementing strategies to strengthen the company's market position. He is responsible for the overall direction and performance of Metacrine.
